Erthropoietin

Journal of Endocrinological Investigation

Volumn 26, Issue 9, 2003, Pages 832-837

  Jelkman, Wolfgang ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Doping; Erythropoiesis; Erythropoietin; Exercise; High altitude; Hypoxia inducible factor 1

Indexed keywords

ANTIANEMIC AGENT; ERYTHROPOIETIN; HEMOGLOBIN; HYPOXIA INDUCIBLE FACTOR 1; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; OXYGEN; RECOMBINANT ERYTHROPOIETIN;

AEROBIC CAPACITY; ALTITUDE; ARTERIAL OXYGEN TENSION; ATHLETE; DIAGNOSTIC TEST; DOPING; DRUG MISUSE; DRUG URINE LEVEL; ENDURANCE; ERYTHROCYTOSIS; EXERCISE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEMOGLOBIN DETERMINATION; HORMONAL REGULATION; HORMONE ACTION; HORMONE RESPONSE; HORMONE STRUCTURE; HORMONE SYNTHESIS; HUMAN; HYDROXYLATION; HYPOXIA; NONHUMAN; OXYGEN AFFINITY; PHYSIOLOGY; PROTEIN ANALYSIS; PROTEIN DEGRADATION; REVIEW; SPORTS MEDICINE; ANOXIA; BIOSYNTHESIS; BLOOD; PATHOPHYSIOLOGY; POLYCYTHEMIA;

ALTITUDE; ANOXIA; DOPING IN SPORTS; ERYTHROPOIETIN; EXERCISE; HEMOGLOBINS; HUMANS; OXYGEN; POLYCYTHEMIA; SPORTS MEDICINE;

EID: 3943097410     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03345232     Document Type: Review

References (70)

1. D'Andrea AD, Zon LI. Erythropoietin receptor. Subunit structure and activation. J Clin Invest 1990, 86: 681-7.
2. Youssoufian H, Longmore G, Neumann D, Yoshimura A, Lodish HF. Structure, function, and activation of the erythropoietin receptor. Blood 1993, 81: 2223-36.
3. Klingmuller U. The role of tyrosine phosphorylation in proliferation and maturation of erythroid progenitor cells - Signals emanating from the erythropoietin receptor. Eur J Biochem 1997, 249: 637-47.
4. Constantinescu SN, Huang LJ, Nam H, Lodish HF. The erythropoietin receptor cytosolic juxtamembrane domain contains an essential, precisely oriented, hydrophobic motif. Mol Cell 2001, 7: 377-85.
5. Koury MJ, Bondurant MC. The molecular mechanism of erythropoietin action. Eur J Biochem 1992, 210: 649-63.
6. De Maria R, Zeuner A, Eramo A, et al. Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1. Nature 1999, 401: 489-93.
7. Jelkmann W. Erythropoietin: Structure, control of production, and function. Physiol Rev, 1992, 72: 449-89.
8. Galson DL, Tan CC, Ratcliffe P, Bunn HF. Comparison of the human and mouse erythropoietin genes shows extensive homology in the flanking regions. Blood 1993, 82: 3321-6.
9. Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 1992, 12: 5447-54.
10. Bunn HF, Poyton RO. Oxygen sensing and molecular adaptation to hypoxia. Physiol Rev 1996, 76: 839-85.
11. Wenger RH, Gassmann M. Oxygen(es) and the hypoxia-inducible factor-1. Biol Chem 1997, 378: 609-16.
12. 2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 1999, 78: 15551-78.
13. 2 tension. Proc Natl Acad Sci USA 1995, 92: 5510-4.
14. Salceda S, Caro J. Hypoxia-inducible factor 1α (HIF-1α) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J Biol Chem 1997, 272: 22642-7.
15. 2-regulated prolyl hydroxylation. Science 2001, 292: 468-72.
16. 2 sensing. Science 2001, 292: 464-8.
17. Epstein ACR, Gleadle JM, McNeill LA, et al. Elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 2001, 107: 43-54.
18. Bruick RK, McKnight SL. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 2001, 294: 1337-40.
19. Masson N, William C, Maxwell PH, Pugh CW, Ratcliffe PJ. Independent function of two destruction domains in hypoxia-inducible factor-α chains activated by prolyl hydroxylation. EMBO J 2001, 20: 5197-206.
20. Ohh M, Park CW, Ivan M, et al. Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel-Lindau protein. Nat Cell Biol, 2000, 2: 423-7.
21. Lando D, Peet DJ, Whelan DA, Gorman JJ, Whitelaw ML. Asparagine hydroxylation of the HIF transactivation domain: A hypoxic switch. Science 2002, 295: 858-61.
22. Maxwell PH, Osmond MK, Pugh CW, et al. Identification of the renal erythropoietin-producing cells using transgenic mice. Kidney Int 1993, 44: 1149-62.
23. Maxwell PH, Ferguson DJ, Nicholls LG, Iredale JP, et al. Sites of erythropoietin production. Kidney Int 1997, 51: 393-401.
24. Tan CC, Eckardt KU, Firth JD, Ratcliffe PJ. Feedback modulation of renal and hepatic erythropoietin mRNA in response to graded anemia and hypoxia. Am J Physiol 1992, 263: F474-81.
25. Fandrey J, Bunn HF. In vivo and in vitro regulation of erythropoietin mRNA: Measurement by competitive polymerase chain reaction. Blood 1993, 81: 617-23.
26. Abbrecht PH, Littell JK. Plasma erythropoietin in men and mice during acclimatization to different altitudes. J Appl Physiol 1972, 32: 54-8.
27. Milledge JS, Cotes PM. Serum erythropoietin in humans at high altitude and its relation to plasma renin. J Appl Physiol 1985, 59: 360-4.
28. Gunga HC, Kirsch K, Rocker L, Schobersberger W. Time course of erythropoietin, triiodothyronine, thyroxine, and thyroid-stimulating hormone at 2,315 m. J Appl Physiol 1994, 76: 1068-72.
29. Richalet JP, Souberbielle JC, Antezana AM, et al. Control of erythropoiesis in humans during prolonged exposure to the altitude of 6,542 m. Am J Physiol 1994, 266: R756-64.
30. Favier R, Spielvogel H, Desplanches D, et al. Training in hypoxia vs training in normoxia in high-altitude natives. J Appl Physiol 1995, 78: 2286-93.
31. Levine BD, Stray-Gundersen J. "Living high-training low": Effect of moderate-altitude acclimatization with low-altitude training on performance. J Appl Physiol 1997, 83: 102-12.
32. Stray-Gundersen J, Chapman RF, Levine BD. "Living high-training low" altitude training improves sea level performance in male and female elite runners. J Appl Physiol 2001, 91: 1113-20.
33. Hahn AG, Gore CJ, Martin DT, Ashenden MJ, Roberts AD, Logan PA. An evaluation of the concept of living at moderate altitude and training at sea level. Comp Biochem Physiol A Mol Integr Physiol 2001, 128: 777-89.
34. Erslev AJ, Caro J. Secondary polycythemia: A boon or a burden? Blood Cells 1984, 10: 177-91.
35. Dainiak N, Spielvogel H, Sorba S, Cudkowicz L. Erythropoietin and the polycythemia of high-altitude dwellers. Adv Exp Med Biol 1989, 271: 17-21.
36. Leon-Velarde F, Monge CC, Vidal A, Carcagno M, Criscuolo M, Bozzini CE. Serum immunoreactive erythropoietin in high altitude natives with and without excessive erythrocytosis. Exp Hematol 1991, 19: 257-60.
37. Winslow RM, Chapman KW, Gibson CC, et al. Different hematologic responses to hypoxia in Sherpas and Quechua Indians. J Appl Physiol 1989, 66: 1561-9.
38. Beall CM, Brittenham GM, Strohl KP, et al. Hemoglobin concentration of high-altitude Tibetans and Bolivian Aymara. Am J Phys Anthropol 1998, 106: 385-400.
39. Berglund B, Birgegard G, Hemmingsson P. Serum erythropoietin in cross-country skiers. Med Sci Sports Exerc 1988, 20: 208-9.
40. Klausen T, Breum L, Fogh-Andersen N, Bennett P, Hippe E. The effect of short and long duration exercise on serum erythropoietin concentrations. Eur J Appl Physiol Occup Physiol 1993, 67: 213-7.
41. Schmidt W, Eckardt KU, Hilgendorf A, Strauch S, Bauer C. Effects of maximal and submaximal exercise under normoxic and hypoxic conditions on serum erythropoietin level. Int J Sports Med 1991, 12: 457-61.
42. Gareau R, Caron C, Brisson GR. Exercise duration and serum erythropoietin level. Horm Metab Res 1991, 23: 355.
43. Ricci G, Masotti M, Paoli-Vitali E, Vedovato M, Zanotti G. Effects of a mixed physical activity (biathlon) on haematologic parameters, red cell 2,3-DPG and creatine, serum erythropoietin, urinary enzymes and microalbumin. Eur J Haematol 1990, 45: 178-9.
44. Ricci G, Masotti M, Paoli-Vitali E, Vedovato M, Zanotti G. Effects of exercise on haematologic parameters, serum iron, serum ferritin, red cell 2,3-diphosphoglycerate and creatine contents, and serum erythropoietin in long-distance runners during basal training. Acta Haematol 1988, 80: 95-8.
45. Schwandt HJ, Heyduck B, Gunga HC, Rocker L. Influence of prolonged physical exercise on the erythropoietin concentration in blood. Eur J Appl Physiol Occup Physiol 1991, 63: 463-6.
46. Schobersberger W, Hobisch-Hagen P, Fries P, et al. Increase in immune activation, vascular endothelial growth factor and erythropoietin after an ultramarathon run at moderate altitude. Immunobiology 2000, 201: 611-20.
47. Klausen T, Dela F, Hippe E, Galbo H. Diurnal variations of serum erythropoietin in trained and untrained subjects. Eur J Appl Physiol Occup Physiol 1993, 67: 545-8.
48. Erslev AJ, Caro J, Besarab A. Why the kidney? Nephron 1985, 41: 213-6.
49. Pagel H, Jelkmann W, Weiss C. A comparison of the effects of renal artery constriction and anemia on the production of erythropoietin. Pflugers Arch 1988, 413: 62-6.
50. Schmidt W, Maassen N, Trost F, Boning D. Training induced effects on blood volume, erythrocyte turnover and haemoglobin oxygen binding properties. Eur J Appl Physiol Occup Physiol 1988, 57: 490-8.
51. Szygula Z. Erythrocytic system under the influence of physical exercise and training. Sports Med 1990, 10: 181-97.
52. Spalding BJ. Black-market biotechnology: Athletes abuse EPO and HGH. Biotechnology NY 1991, 9: 1050-3.
53. Eichner ER. Better dead than second. J Lab Clin Med 1992, 120: 359-60.
54. Ekblom B, Berglund B. Effect of erythropoietin administration on maximal aerobic power in man. Scand J Med Sci Sports 1991, 1: 88-93.
55. Audran M, Gareau R, Matecki S, et al. Effects of erythropoietin administration in training athletes and possible indirect detection in doping control. Med Sci Sports Exerc 1999, 5: 639-45.
56. Lasne F, De Ceaurriz J. Recombinant erythropoietin in urine. Nature 2000, 405: 635.
57. Simon TL. Induced erythrocythemia and athletic performance. Semin Hematol 1994, 31: 128-33.
58. Lippi G, Guidi G. Laboratory screening for erythropoietin abuse in sport: An emerging challenge. Clin Chem Lab Med 2000, 38: 13-9.
59. Spivak JL. Sports hematology: Serious concept or trivial pursuit. Introduction. Semin Hematol 1994, 31: 99-101.
60. Thomas DJ, Marshall J, Russell RW, et al. Effect of haematocrit on cerebral blood-flow in man. Lancet 1977, 2: 941-3.
61. Wagner K, Katschinski DM, Hasegawa J, et al. Chronic inborn erythrocytosis leads to cardiac dysfunction and premature death in mice overexpressing erythropoietin. Blood 2001, 97: 536-42.
62. Ruschitzka FT, Wenger RH, Stallmach T, et al. Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin. Proc Natl Acad Sci USA 2000, 97: 11609-13.
63. Casoni I, Ricci G, Ballarin E, et al. Hematological indices of erythropoietin administration in athletes. Int J Sports Med 1993, 14: 307-11.
64. Parisotto R, Gore CJ, Hahn AG, et al. Reticulocyte parameters as potential discriminators of recombinant human erythropoietin abuse in elite athletes. Int J Sports Med 2000, 21: 471-9.
65. Parisotto R, Ashenden MJ, Emslie KR, et al. Detection of recombinant human erythropoietin abuse in athletes utilizing markers of altered erythropoiesis. Haematologica 2001, 86: 128-37.
66. Magnani M, Corsi D, Bianchi M, et al. Identification of blood erythroid markers useful in revealing erythropoietin abuse in athletes. Blood Cells Mol Dis 2002, 27: 559-71.
67. Egrie JK, Browne JK. Development and characterization of novel erythropoiesis stimulating protein (NESP). Br J Cancer 2001, 84: 3-10.
68. Friedmann T, Koss JO. Gene transfer and athletics - An impending problem. Mol Ther 2001, 3: 819-20.
69. Naffakh N, Danos O. Gene transfer for erythropoiesis enhancement. Mol Med Today 1996, 2: 343-8.
70. Rinsch C, Regulier E, Deglon N, Dalle B, Beuzard Y, Aebischer P. A gene therapy approach to regulated delivery of erythropoietin as a function of oxygen tension. Hum Gene Ther 1997, 8: 1881-9.